Depo-provera and Salivary hypersecretion - a phase IV clinical study of FDA data
Summary:
Salivary hypersecretion is reported as a side effect among people who take Depo-provera (medroxyprogesterone acetate), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Abilify, and have Schizophrenia.
The phase IV clinical study analyzes which people have Salivary hypersecretion when taking Depo-provera. It is created by eHealthMe based on reports of 15,804 people who have side effects when taking Depo-provera from the FDA, and is updated regularly.
What is Depo-provera?
Depo-provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 17,093 Depo-provera users. Check the latest studies of Depo-provera.
What is Salivary hypersecretion?
Salivary hypersecretion (excess saliva secretion) is found to be associated with 779 drugs and 1,338 conditions by eHealthMe. Check the latest studies of Salivary hypersecretion.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
15,804 people reported to have side effects when taking Depo-provera.
Among them, 16 people (0.1%) have Salivary hypersecretion.

Among these 16 people:
How long have people been on Depo-provera when they have Salivary hypersecretion? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Salivary hypersecretion when taking Depo-provera? *
- female: 93.33 %
- male: 6.67 %
What is the age of people who have Salivary hypersecretion when taking Depo-provera? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 58.33 %
- 30-39: 25.0 %
- 40-49: 16.67 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Depo-provera? *
- Abilify: 4 people, 25.00%
- Risperidone: 3 people, 18.75%
- Diazepam: 3 people, 18.75%
- Klonopin: 3 people, 18.75%
- Sertraline: 1 person, 6.25%
- Risperdal: 1 person, 6.25%
- Potassium: 1 person, 6.25%
- Navane: 1 person, 6.25%
- Methyldopa: 1 person, 6.25%
- Methergine: 1 person, 6.25%
What are other side effects people have besides Salivary hypersecretion? *
- Nausea (feeling of having an urge to vomit): 6 people, 37.50%
- Abdominal Pain: 5 people, 31.25%
- Drowsiness: 4 people, 25.00%
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 3 people, 18.75%
- Headache (pain in head): 3 people, 18.75%
- Pinworms: 3 people, 18.75%
- Acne (skin problems that cause pimples): 3 people, 18.75%
- Amenorrhea (absence of a menstrual period in a woman of reproductive age): 3 people, 18.75%
- Application Site Pain: 3 people, 18.75%
- Breast Pain: 3 people, 18.75%
What are the existing conditions these people have? *
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 18.75%
- Stress And Anxiety: 1 person, 6.25%
- Sleep Disorder: 1 person, 6.25%
- Sexually Inappropriate Behavior: 1 person, 6.25%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 6.25%
- Sedation: 1 person, 6.25%
- Psychiatric Symptom: 1 person, 6.25%
- Mental Disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability): 1 person, 6.25%
- Insomnia (sleeplessness): 1 person, 6.25%
- Hormone Level Abnormal: 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Depo-provera and have Salivary hypersecretion?
- Check whether Salivary hypersecretion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Depo-provera:
- Depo-provera (17,093 reports)
Salivary hypersecretion treatments and more:
- Salivary hypersecretion (13,837 reports)
How severe was Salivary hypersecretion and when was it recovered:
Expand to all the drugs that have ingredients of medroxyprogesterone acetate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Depo-provera:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Salivary hypersecretion:
- Salivary hypersecretion (779 drugs)
Browse all the conditions that are associated with Salivary hypersecretion:
- Salivary hypersecretion (1,338 conditions)
Related publications that referenced our studies
- Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
- Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
How the study uses the data?
The study uses data from the FDA. It is based on medroxyprogesterone acetate (the active ingredients of Depo-provera) and Depo-provera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Parsabiv cause Insomnia? - a second ago
- Could Vidaza cause Lower Gastrointestinal Haemorrhage? - 15 seconds ago
- Splenomegaly and Fever - 21 seconds ago
- Could Tamsulosin Hydrochloride cause Kidney Infection (Pyelonephritis)? - 21 seconds ago
- Estrostep Fe vs. Loseasonique, side effect and effectiveness comparison - 25 seconds ago
- Could Phenergan cause Salivary Hypersecretion? - 47 seconds ago
- Could Ticagrelor cause Stress And Anxiety? - 57 seconds ago
- Drug interactions of Senna and Enbrel - a minute ago
- Could Ultravist cause Abdominal Pain? - a minute ago
- Could Tysabri cause Intervertebral Disc Protrusion? - a minute ago